Eugene Sherman, MD, chair of the American College of Cardiology’s Advocacy Steering Committee and Political Action Committee, shares his experience meeting with other cardiovascular societies to make a case to members of Congress to eliminate the Sustainable Growth Rate formula and boost healthcare quality in a blog post.

The first project to receive an investment from the American Heart Association’s Science & Technology Accelerator Program will be jointly developed by CytoVas, LLC and BD Biosciences, the firms announced.

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced the results of a POZEN sponsored study at the Academy of Managed Care Pharmacy’s 25th Annual Meeting and Expo on April 4, 2013. 

Atrial fibrillation (AF) places a heavy financial burden on the U.S. healthcare system, but cardiologists may help to chip away at these costs.

Despite data supporting the clinical benefits of remote monitoring, some practices are resisting adoption due to the potential liability of receiving alerts on a 24-hour basis. Four experts share their opinions on how practices should approach these considerations.

Technological improvements in image acquisition and software processing in nuclear cardiology should allow physicians to shave patient imaging times dramatically or cut radiation doses fourfold, according to a new preferred practice statement from the American Society of Nuclear Cardiology (ASNC).

Two million neurons die per every minute that a stroke goes untreated, making rapid diagnosis and treatment crucial for the best outcomes. However, 45 percent of Americans live more than 60 minutes away from a primary stroke center. Enter telemedicine: telestroke networks have sprung up across the U.S., and are rapidly expanding, delivering revenue gains and improving patient outcomes.